Chronic Hepatitis B and C: Legal Status and Treatment Advances

Chronic hepatitis and carrier status concerns?

Hello, doctor.
I would like to ask if chronic hepatitis B and C are classified as notifiable infectious diseases under the Communicable Disease Control Act.
Additionally, if a person recovers from hepatitis B but becomes a permanent carrier, would this situation still be considered a notifiable infectious disease? Also, I recently saw news about new medications for hepatitis C.
Can these new drugs cure chronic hepatitis C? Thank you.

Mr. Wang, 20~29 year old female. Ask Date: 2016/11/17

Dr. Chen Shidian reply Gastroenterology and Hepatology

Hello, Mr.
BC.
Hepatitis B is only required to be reported as a statutory infectious disease upon initial infection and first diagnosis.
Hepatitis C can be completely cured with oral medication, although the cost is high.
Hepatitis B can only be managed to maintain a carrier state with normal liver function.
Changhua Hospital cares about your health.
Chen Shidian

Reply Date: 2016/11/17

More Info

Chronic Hepatitis B and C are significant public health concerns, and understanding their legal status and treatment advancements is crucial for both patients and healthcare providers.
Firstly, regarding the legal status of chronic Hepatitis B and C under the Infectious Disease Control Act, both conditions are classified as notifiable infectious diseases in many jurisdictions, including Taiwan. This means that healthcare providers are required to report cases of these infections to public health authorities. The rationale behind this classification is to monitor and control the spread of these viruses, which can lead to serious health complications such as liver cirrhosis and hepatocellular carcinoma (liver cancer).
When a person recovers from Hepatitis B but becomes a chronic carrier (also known as a "chronic Hepatitis B surface antigen positive" individual), they may still be considered a public health concern. Chronic carriers can transmit the virus to others, which is why they are often still subject to public health regulations. However, the specifics can vary based on local laws and regulations, so it is essential to consult with a healthcare professional or legal expert familiar with the laws in your area.

As for Hepatitis C, recent advancements in treatment have been groundbreaking. The introduction of direct-acting antiviral (DAA) medications has transformed the landscape of Hepatitis C treatment. These new drugs can effectively cure the virus in a significant majority of patients, often with a treatment duration of only 8 to 12 weeks. The cure rate for chronic Hepatitis C with these new therapies can exceed 95%, making it one of the most successful treatments in infectious disease medicine.
The mechanism of these DAAs involves targeting specific steps in the Hepatitis C virus life cycle, which prevents the virus from replicating. This targeted approach minimizes side effects and enhances the overall efficacy of the treatment. It is essential for patients to undergo thorough screening and evaluation to determine the most appropriate treatment regimen, as factors such as the genotype of the virus and the presence of liver damage can influence treatment decisions.

In summary, chronic Hepatitis B and C are legally recognized infectious diseases that require monitoring and reporting. Chronic carriers of Hepatitis B remain a public health concern due to their potential to transmit the virus. On the other hand, the advent of new antiviral therapies for Hepatitis C offers hope for a cure, significantly improving patient outcomes and reducing the burden of this disease on public health systems. Patients should engage in open discussions with their healthcare providers to understand their condition, treatment options, and the implications of their legal status regarding infectious disease regulations.

Similar Q&A

Navigating Hepatitis C Treatment: Options, Costs, and Lifestyle Considerations

Hello, doctors. I have been suffering from liver disease for a long time. Five years ago, a blood test revealed that I had both hepatitis B and C viruses. A month later, I went to a Christian hospital for further testing, and it confirmed only hepatitis C. Since then, I have been...

Dr. Yang Peizhen reply Gastroenterology and Hepatology
Hello! First of all, it must be emphasized that hepatitis C is transmitted through blood and bodily fluids, and is fundamentally unrelated to diet. Chronic hepatitis C has a high rate of viral mutation, which makes treatment outcomes less than ideal. Currently, the most effective...

Managing Chronic Hepatitis C and Kidney Deficiency: A Holistic Approach

Hello, doctor. Three years ago, I was diagnosed with hepatitis C during a health check-up, and my liver enzyme level (GPT) was 107. Since then, I have been undergoing regular ultrasound examinations every three months, which have shown no abnormalities. However, my enzyme levels ...

Dr. Lin Qingzhong reply Traditional Chinese Medicine
Hello, user: Hepatitis C, like I previously mentioned regarding Hepatitis B, is difficult to eradicate completely. The main difference between Hepatitis B and C lies in the type of virus causing the disease; otherwise, the mechanisms of disease development are quite similar. Bot...

Understanding Chronic Hepatitis C: Treatment Options and Definition

Chronic hepatitis C treatment methods include antiviral medications such as direct-acting antivirals (DAAs), which are highly effective in curing the infection. Treatment regimens typically last from 8 to 12 weeks, depending on the specific medication used and the patient's ...

Dr. Chen Jingwen reply Internal Medicine
After infection with the hepatitis C virus, there is an 80-90% chance of developing chronic hepatitis. After 20 years, 20% of those with chronic hepatitis may progress to cirrhosis, and among cirrhosis patients, there is an annual incidence of 3-6% for hepatocellular carcinoma. C...

Enhancing Interferon Treatment for Chronic Hepatitis B with Baraclude

Hello, Doctor. I am a carrier of hepatitis B and have been regularly undergoing ultrasound and blood tests for a long time. However, since November of last year, my liver enzyme levels have been rising to over 200, and my surface antigen level is at 80,000. My attending physician...

Dr. Chen Shidian reply Gastroenterology and Hepatology
Hello, Sir: Q1 Combination therapy is a recommendation based on professional experience, and while it is not inappropriate, there are currently no definitive human trial results to support it. Therefore, it is unclear what the best combination would be. Q2 There will be no re...